These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9484786)
21. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome. Kulkarni S; Reiter A; Smedley D; Goldman JM; Cross NC Genomics; 1999 Jan; 55(1):118-21. PubMed ID: 9889006 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using fluorescence in situ hybridization. Chernova O; Still I; Kalaycio M; Hoeltge G; Cowell JK Genes Chromosomes Cancer; 1998 Feb; 21(2):160-5. PubMed ID: 9491328 [TBL] [Abstract][Full Text] [Related]
23. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder. Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332 [TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949 [TBL] [Abstract][Full Text] [Related]
25. Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9). Sambani C; La Starza R; Pierini V; Vandenberghe P; Gonzales-Aguilera JJ; Rigana H; Koumbi D; Manola KN; Stavropoulou C; Georgakakos VN; Pagoni M; Wlodarska I; Mecucci C Cancer Genet Cytogenet; 2005 Oct; 162(1):45-9. PubMed ID: 16157199 [TBL] [Abstract][Full Text] [Related]
26. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders. Gallagher G; Horsman DE; Tsang P; Forrest DL Cancer Genet Cytogenet; 2008 Feb; 181(1):46-51. PubMed ID: 18262053 [TBL] [Abstract][Full Text] [Related]
27. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Li F; Zhai YP; Tang YM; Wang LP; Wan PJ Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110 [TBL] [Abstract][Full Text] [Related]
28. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Suzan F; Guasch G; Terre C; Garcia I; Bastie JN; Maarek O; Ribaud P; Gluckman E; Daniel MT; Pébusque MJ; Castaigne S Br J Haematol; 2003 Apr; 121(2):312-4. PubMed ID: 12694254 [TBL] [Abstract][Full Text] [Related]
29. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224 [TBL] [Abstract][Full Text] [Related]
30. Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12). Röijer E; Kas K; Klawitz I; Bullerdiek J; Van de Ven W; Stenman G Genes Chromosomes Cancer; 1996 Nov; 17(3):166-71. PubMed ID: 8946195 [TBL] [Abstract][Full Text] [Related]
31. Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder. O'Reilly J; Crawford J; Uzaraga J; Cannell P Cancer Genet Cytogenet; 2005 Apr; 158(1):81-3. PubMed ID: 15771910 [TBL] [Abstract][Full Text] [Related]
32. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia. Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352 [TBL] [Abstract][Full Text] [Related]
33. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult. Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307 [No Abstract] [Full Text] [Related]
34. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene. Yamamoto K; Kawano H; Nishikawa S; Yakushijin K; Okamura A; Matsui T Eur J Haematol; 2006 Oct; 77(4):349-54. PubMed ID: 16879608 [TBL] [Abstract][Full Text] [Related]
35. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma]. Laureys GG Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670 [TBL] [Abstract][Full Text] [Related]
36. A novel translocation, t(9;11)(q33;q23) involving the HRX gene in an acute monocytic leukemia. Le Coniat M; Romana SP; Bernard O; Flexor MA; Hillion J; Cherif D; Berger R C R Acad Sci III; 1993 Jul; 316(7):692-7. PubMed ID: 8019892 [TBL] [Abstract][Full Text] [Related]
37. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature. Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135 [TBL] [Abstract][Full Text] [Related]
38. A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13)(p11;q12): a Japanese case. Matsumoto K; Morita K; Takada S; Sakura T; Shiozaki H; Murakami H; Miyawaki S Int J Hematol; 1999 Dec; 70(4):278-82. PubMed ID: 10643154 [TBL] [Abstract][Full Text] [Related]
39. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36). Sinclair P; Harrison CJ; Jarosová M; Foroni L Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375 [TBL] [Abstract][Full Text] [Related]
40. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3. Tzankov A; Sotlar K; Muhlematter D; Theocharides A; Went P; Jotterand M; Horny HP; Dirnhofer S J Clin Pathol; 2008 Aug; 61(8):958-61. PubMed ID: 18663058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]